CONMED Corporation

BMV:CNMD * Stock Report

Market Cap: Mex$49.3b

CONMED Management

Management criteria checks 3/4

CONMED's CEO is Curt Hartman, appointed in Jul 2014, has a tenure of 10.33 years. total yearly compensation is $7.76M, comprised of 12.2% salary and 87.8% bonuses, including company stock and options. directly owns 0.3% of the company’s shares, worth MX$149.27M. The average tenure of the management team and the board of directors is 5.8 years and 9.3 years respectively.

Key information

Curt Hartman

Chief executive officer

US$7.8m

Total compensation

CEO salary percentage12.2%
CEO tenure10.3yrs
CEO ownership0.3%
Management average tenure5.8yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Curt Hartman's remuneration changed compared to CONMED's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$132m

Jun 30 2024n/an/a

US$99m

Mar 31 2024n/an/a

US$82m

Dec 31 2023US$8mUS$950k

US$64m

Sep 30 2023n/an/a

US$58m

Jun 30 2023n/an/a

US$88m

Mar 31 2023n/an/a

-US$94m

Dec 31 2022US$8mUS$946k

-US$81m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

US$68m

Dec 31 2021US$9mUS$918k

US$63m

Sep 30 2021n/an/a

US$62m

Jun 30 2021n/an/a

US$54m

Mar 31 2021n/an/a

US$13m

Dec 31 2020US$6mUS$888k

US$10m

Sep 30 2020n/an/a

US$311k

Jun 30 2020n/an/a

US$431k

Mar 31 2020n/an/a

US$34m

Dec 31 2019US$6mUS$842k

US$29m

Sep 30 2019n/an/a

US$29m

Jun 30 2019n/an/a

US$28m

Mar 31 2019n/an/a

US$31m

Dec 31 2018US$5mUS$791k

US$41m

Sep 30 2018n/an/a

US$72m

Jun 30 2018n/an/a

US$73m

Mar 31 2018n/an/a

US$71m

Dec 31 2017US$3mUS$753k

US$55m

Compensation vs Market: Curt's total compensation ($USD7.76M) is above average for companies of similar size in the MX market ($USD694.06K).

Compensation vs Earnings: Curt's compensation has been consistent with company performance over the past year.

CEO

Curt Hartman (60 yo)

10.3yrs

Tenure

US$7,764,615

Compensation

Mr. Curt R. Hartman serves as the Director of CONMED Corporation since October 31, 2024 and Chief Executive Officer and President of CONMED Corporation since November 09, 2014, He served as Chairman of the...

Leadership Team

NamePositionTenureCompensationOwnership
Curt Hartman
President10.3yrsUS$7.76m0.30%
MX$ 149.3m
Todd Garner
Executive VP6.8yrsUS$2.87m0.00073%
MX$ 360.0k
Patrick Beyer
Chief Operating Officerless than a yearUS$3.30m0.035%
MX$ 17.3m
Richard Glaze
Chief Information Officerno datano data0.00083%
MX$ 409.3k
Hollie Foust
General Counsel & Corporate Secretaryno datano datano data
Peter Shagory
Executive Vice President of Strategy & Corporate Development9.5yrsno data0.012%
MX$ 5.9m
Shanna Cotti-Osmanski
Executive VP of Information Technology & CIO4.7yrsno datano data
John Ferrell
Executive Vice President of Human Resources1.9yrsno data0.0023%
MX$ 1.1m
David Murray
President of ConMed Electrosurgery20.3yrsUS$572.33kno data
Johonna Pelletier
VP of Tax & Treasurer9.6yrsno data0.0043%
MX$ 2.1m
Kimberly Lockwood
Interim Corporate Controllerless than a yearno datano data

5.8yrs

Average Tenure

56yo

Average Age

Experienced Management: CNMD *'s management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Curt Hartman
President10.7yrsUS$7.76m0.30%
MX$ 149.3m
John Workman
Independent Director9.3yrsUS$257.37k0.066%
MX$ 32.6m
David Bronson
Independent Director9.3yrsUS$264.87k0.054%
MX$ 26.8m
Brian Concannon
Independent Director11.3yrsUS$257.37k0.031%
MX$ 15.4m
LaVerne Council
Independent Director4.9yrsUS$257.37k0.012%
MX$ 5.7m
Martha Aronson
Independent Chair of the Board8.8yrsUS$292.37k0.045%
MX$ 22.2m
Charles Farkas
Independent Director10.3yrsUS$249.87k0.066%
MX$ 32.5m
Barbara Schwarzentraub
Independent Director5.2yrsUS$264.87k0.017%
MX$ 8.5m

9.3yrs

Average Tenure

64yo

Average Age

Experienced Board: CNMD *'s board of directors are considered experienced (9.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/26 11:58
End of Day Share Price 2024/08/29 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CONMED Corporation is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBarclays
Travis SteedBofA Global Research
Kristen StewartCL King & Associates, Inc.